Voranigo
Total Payments
$19.9M
Transactions
1,142
Doctors
523
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $19.9M | 1,142 | 523 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $19.9M | 524 | 99.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,315 | 9 | 0.1% |
| Food and Beverage | $16,694 | 588 | 0.1% |
| Travel and Lodging | $7,405 | 21 | 0.0% |
Payments by Type
Research
$19.9M
524 transactions
General
$41,414
618 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| STUDY OF VORASIDENIB, AG-881, IN PARTICIPANTS WITH RESIDUAL OR RECURRENT GRADE 2 GLIOMA WITH AN IDH1 OR IDH2 MUTATION, INDIGO | Servier BioInnovation | $19.9M | 0 |
Top Doctors Receiving Payments for Voranigo
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Duarte, CA | $19.9M | 524 |
| , M.D | Neurology | Chicago, IL | $6,250 | 5 |
| , PA | Physician Assistant | Rochester, NY | $5,095 | 8 |
| , M.D | Neurology | Los Angeles, CA | $3,740 | 3 |
| , M.D | Neurology | Minneapolis, MN | $3,169 | 4 |
| , APRN, CNP | Nurse Practitioner | Chicago, IL | $2,467 | 11 |
| , M.D | Neurology | Newton, MA | $2,180 | 4 |
| , M.D., PH.D | Hematology & Oncology | Seattle, WA | $2,002 | 2 |
| , MD | Neurology | Boca Raton, FL | $1,226 | 6 |
| Magdalena Skiba | Family | Maspeth, NY | $193.11 | 2 |
| , MD | Neurology | New York, NY | $169.15 | 1 |
| , NP | Registered Nurse | New York, NY | $169.15 | 1 |
| , FNP | Nurse Practitioner | New York, NY | $169.15 | 1 |
| , FNP-C | Registered Nurse | New York, NY | $169.15 | 1 |
| , MS, FNP | Family | New York, NY | $169.15 | 1 |
| , NURSE PRACTITIONER | Nurse Practitioner | Orange, CA | $146.52 | 1 |
| , NP | Family | Fullerton, CA | $146.52 | 1 |
| , NP | Adult Health | Orange, CA | $146.52 | 1 |
| , MD | Complex Family Planning | Taten Island, NY | $146.52 | 1 |
| , APRN | Nurse Practitioner | Durham, NC | $129.53 | 1 |
| , NP | Adult Health | Durham, NC | $129.53 | 1 |
| , APRN | Acute Care | Durham, NC | $129.53 | 1 |
| Mary Affronti | Nurse Practitioner | Durham, NC | $129.53 | 1 |
| , AGPCNP-BC | Adult Health | Durham, NC | $129.53 | 1 |
| , PA | Physician Assistant | Durham, NC | $129.53 | 1 |
Ad
Manufacturing Companies
- Servier BioInnovation $19.9M
- SERVIER PHARMACEUTICALS LLC $41,414
Product Information
- Type Drug
- Total Payments $19.9M
- Total Doctors 523
- Transactions 1,142
About Voranigo
Voranigo is a drug associated with $19.9M in payments to 523 healthcare providers, recorded across 1,142 transactions in the CMS Open Payments database. The primary manufacturer is Servier BioInnovation.
Payment data is available from 2024 to 2024. In 2024, $19.9M was paid across 1,142 transactions to 523 doctors.
The most common payment nature for Voranigo is "Unspecified" ($19.9M, 99.8% of total).
Voranigo is associated with 1 research study, including "STUDY OF VORASIDENIB, AG-881, IN PARTICIPANTS WITH RESIDUAL OR RECURRENT GRADE 2 GLIOMA WITH AN IDH1 OR IDH2 MUTATION, INDIGO" ($19.9M).